At 8 mg doses, the range was 17-60% depending on the specific trial and titration speed
Therapeutic dosing uses higher doses to treat existing neuropathy or deficiency
In vitro studies demonstrate that treatment with the peptide BPC-157 increases GHR mRNA and protein levels in a dose- and time-dependent manner, enhancing the fibroblasts responsiveness to growth hormone and promoting cell proliferation essential for tendon healing
Its original development focused on neurodegenerative conditions like Parkinsons and Alzheimers, and while promising fat loss data emerged, it has yet to receive regulatory approval for commercial use
No inter-group differences were observed in initial deficits, time metrics, or thrombolysis administration
By the way, even if you dont have pernicious anemia, but a severe B12 deficiency due to other causes, B12 shots are still the way to go